Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Ciarrocchi

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Nature Communications|March 23, 2024
BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3Francesca Reggiani, Giovanna Talarico, Giulia Gobbi, et al.
Cell Proliferation|September 3, 2024
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple-negative breast cancer (TNBC) cellsTeresa Rossi, Egidio Iorio, Mattea Chirico, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 28, 2025
CDKN2A deletion is associated with immune desertification in diffuse pleural mesotheliomaFederica Torricelli, Benedetta Donati, Veronica Manicardi, et al.
Cell Death & Disease|November 18, 2023
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signalingGiulia Gobbi, Alessandra Grieco, Federica Torricelli, et al.
NAR Cancer|August 1, 2022
KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM)Eugenia Lorenzini, Federica Torricelli, Raffaella Zamponi, et al.
Hematological Oncology|May 23, 2022
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic studyRexhep Durmo, Benedetta Donati, Louis Rebaud, et al.
Haematologica|September 8, 2022
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteinsElisa Taiana, Cecilia Bandini, Vanessa Katia Favasuli, et al.
Oncotarget|February 9, 2018
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid CarcinomasGreta Gandolfi, Moira Ragazzi, Dario de Biase, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2019
A Gene Expression-based Model to Predict Metabolic Response After Two Courses of ABVD in Hodgkin Lymphoma PatientsStefano Luminari, Benedetta Donati, Massimiliano Casali, et al.
Scientific Reports|May 20, 2017
MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell lineBeate Rinner, Greta Gandolfi, Katharina Meditz, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Nature Communications|March 23, 2024
BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3Francesca Reggiani, Giovanna Talarico, Giulia Gobbi, et al.
Cell Proliferation|September 3, 2024
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple-negative breast cancer (TNBC) cellsTeresa Rossi, Egidio Iorio, Mattea Chirico, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 28, 2025
CDKN2A deletion is associated with immune desertification in diffuse pleural mesotheliomaFederica Torricelli, Benedetta Donati, Veronica Manicardi, et al.
Cell Death & Disease|November 18, 2023
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signalingGiulia Gobbi, Alessandra Grieco, Federica Torricelli, et al.
NAR Cancer|August 1, 2022
KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM)Eugenia Lorenzini, Federica Torricelli, Raffaella Zamponi, et al.
Hematological Oncology|May 23, 2022
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic studyRexhep Durmo, Benedetta Donati, Louis Rebaud, et al.
Haematologica|September 8, 2022
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteinsElisa Taiana, Cecilia Bandini, Vanessa Katia Favasuli, et al.
Oncotarget|February 9, 2018
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid CarcinomasGreta Gandolfi, Moira Ragazzi, Dario de Biase, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2019
A Gene Expression-based Model to Predict Metabolic Response After Two Courses of ABVD in Hodgkin Lymphoma PatientsStefano Luminari, Benedetta Donati, Massimiliano Casali, et al.
Scientific Reports|May 20, 2017
MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell lineBeate Rinner, Greta Gandolfi, Katharina Meditz, et al.
Pageof 13